Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
funding
health
startups
america
arch venture partners
artificial intelligence
bill martin
bio
biotech ipos
boston
boston blog main
boston top stories
chronic pain
clinical trials
drug development
dyne therapeutics
europe
executive
fda
gv
health/life sciences
johnson & johnson
julie sunderland
khosla ventures
life sciences
lumithera
machine learning
managing partner
medicine
metacrine
myotonic dystrophy type 1
national blog main
neuroscience
new york
nonalcoholic steatohepatitis
pain
physical therapy
polaris partners
rare disease drugs
What
company
4
×
disorders
4
×
million
raised
based
developing
health
muscular
new
raises
round
therapeutics
treat
ago
announced
approach
betting
billion
blackthorn
brings
challenges
costs
create
develop
device
diseases
drug
drugs
dyne
dyne’s
effective
europe
financing
finding
founded
funding
genetic
gv
healthcare
ipo
Language
unset
Current search:
disorders
×
company
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@geekwire.com
3 years ago
Medical device startup LumiThera raises $14M to further develop treatment for ocular disorders
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@techcrunch.com
5 years ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures